GLP-1 drugs such as Wegovy, Ozempic, and Zepbound are a class of medications primarily taken to treat Type 2 diabetes and, more recently, obesity. Research indicates many people taking GLP-1s for ...

Three months after starting one of the new GLP-1 weight-loss drugs, more than a quarter of patients have already quit the medications, and by a year from first use more than a third have stopped ...

Nearly 60% of Americans who started taking weight-loss drugs between 2014 and 2023 didn’t continue long enough to see meaningful health benefits, according to a study of people covered by ...

We include products we think are useful for our readers. If you buy through links on this page, we may earn a small commission. Here’s our process. Injectable GLP-1 medication can help manage ...

Blue Cross Blue Shield of Michigan will drop coverage GLP-1 obesity drugs in fully insured large group commercial plans ...

The number of American teens and young adults who've been prescribed one of the new GLP-1 weight-loss drugs soared nearly seven-fold between 2020 and 2023, a new report finds. That's compared to ...

Three months after starting one of the new GLP-1 weight-loss drugs, more than a quarter of patients have already quit the medications, and by a year from first use more than a third have stopped, new ...